olmesartan medoxomil

Generic: olmesartan medoxomil

Labeler: inventia healthcare limited
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name olmesartan medoxomil
Generic Name olmesartan medoxomil
Labeler inventia healthcare limited
Dosage Form TABLET, COATED
Routes
ORAL
Active Ingredients

olmesartan medoxomil 5 mg/1

Manufacturer
Inventia Healthcare Limited

Identifiers & Regulatory

Product NDC 49252-065
Product ID 49252-065_f29310d1-7b00-4057-9dd1-d9a69f542d5e
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA208659
Listing Expiration 2026-12-31
Marketing Start 2020-05-29

Pharmacologic Class

Classes
angiotensin 2 receptor antagonists [moa] angiotensin 2 receptor blocker [epc]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 49252065
Hyphenated Format 49252-065

Supplemental Identifiers

RxCUI
349373 349401 349405
UPC
0349252066106 0349252065109 0349252067103
UNII
6M97XTV3HD

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name olmesartan medoxomil (source: ndc)
Generic Name olmesartan medoxomil (source: ndc)
Application Number ANDA208659 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 5 mg/1
source: ndc
Packaging
  • 30 TABLET, COATED in 1 BOTTLE (49252-065-10)
  • 90 TABLET, COATED in 1 BOTTLE (49252-065-12)
  • 1000 TABLET, COATED in 1 BOTTLE (49252-065-18)
source: ndc

Packages (3)

49252-065-10 30 TABLET, COATED in 1 BOTTLE (49252-065-10) 49252-065-12 90 TABLET, COATED in 1 BOTTLE (49252-065-12) 49252-065-18 1000 TABLET, COATED in 1 BOTTLE (49252-065-18)

Ingredients (1)

olmesartan medoxomil (5 mg/1)

Linked Drug Pages (1)

OLMESARTAN MEDOXOMIL ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "f29310d1-7b00-4057-9dd1-d9a69f542d5e", "openfda": {"upc": ["0349252066106", "0349252065109", "0349252067103"], "unii": ["6M97XTV3HD"], "rxcui": ["349373", "349401", "349405"], "spl_set_id": ["05a807bf-5175-43a2-a676-215bba2645a8"], "manufacturer_name": ["Inventia Healthcare Limited"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET, COATED in 1 BOTTLE (49252-065-10)", "package_ndc": "49252-065-10", "marketing_start_date": "20200529"}, {"sample": false, "description": "90 TABLET, COATED in 1 BOTTLE (49252-065-12)", "package_ndc": "49252-065-12", "marketing_start_date": "20200529"}, {"sample": false, "description": "1000 TABLET, COATED in 1 BOTTLE (49252-065-18)", "package_ndc": "49252-065-18", "marketing_start_date": "20200529"}], "brand_name": "OLMESARTAN MEDOXOMIL", "product_id": "49252-065_f29310d1-7b00-4057-9dd1-d9a69f542d5e", "dosage_form": "TABLET, COATED", "pharm_class": ["Angiotensin 2 Receptor Antagonists [MoA]", "Angiotensin 2 Receptor Blocker [EPC]"], "product_ndc": "49252-065", "generic_name": "olmesartan medoxomil", "labeler_name": "Inventia Healthcare Limited", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "OLMESARTAN MEDOXOMIL", "active_ingredients": [{"name": "OLMESARTAN MEDOXOMIL", "strength": "5 mg/1"}], "application_number": "ANDA208659", "marketing_category": "ANDA", "marketing_start_date": "20200529", "listing_expiration_date": "20261231"}